Cancer immunology II: molecular and cellular bases of carcinogenesis
Descripción del Articulo
Technological advances applied to preclinical and clinical scientific research have significantly enabled the broadening of knowledge regarding neoplastic cells biology in the last two decades. The characterization of genetic and epigenetic alterations which are involved in carcinogenesis; the molec...
Autores: | , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2019 |
Institución: | Universidad de San Martín de Porres |
Repositorio: | Horizonte médico |
Lenguaje: | español |
OAI Identifier: | oai:horizontemedico.usmp.edu.pe:article/980 |
Enlace del recurso: | https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/980 |
Nivel de acceso: | acceso abierto |
Materia: | Carcinogénesis Microambiente tumoral Proteínas oncogénicas Carcinogenesis Tumor microenvironment Oncogene proteins |
Sumario: | Technological advances applied to preclinical and clinical scientific research have significantly enabled the broadening of knowledge regarding neoplastic cells biology in the last two decades. The characterization of genetic and epigenetic alterations which are involved in carcinogenesis; the molecular subclassification of tumors; the understanding of normal and neoplastic cells interactions in the tumor microenvironment; and the description of molecular bases that explain the influence of factors such as exercise, diet and microbiota composition on cancer progression have contributed to support the importance of precision medicine in cancer. The present research reviews the so-called "hallmarks of cancer" and their "enabling characteristics", i.e. those properties inherent to cancer cells that allow to evade intrinsic and extrinsic mechanisms of carcinogenesis control. This paper is a follow-up review of studies on cancer immunology that started with the presentation of the molecular and cellular bases of the anti-tumoral immune response, and will eventually focus on the manipulation of the relationship between the immune system and malignancies as a cancer treatment strategy. |
---|
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).